The current valuation score of MDxHealth SA is 9.04, ranking 58 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.78, which is -21.09% below the recent high of -0.61 and -745.56% above the recent low of -6.59.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.